Grant: Discovery Grants Program - Individual
University of Guelph
$50,000.00
Host response to lentiviral infection
FY 2012-13
Summary
Among lentiviruses, only the human immunodeficiency virus (HIV) and the feline immunodeficiency virus (FIV) utilize a combination of ubiquitous chemokine and specific T-cell receptors for viral entry, and cause immunodeficiency in their natural hosts. FIV has co-evolved with domestic and wild cats for a longer time than HIV has with humans, and disease associated with FIV infection develops more gradually in cats than immunodeficiency in HIV-infected people. Further, some cats infected with FIV do not get ill at all, while most others eventually succumb to the disease. Identifying feline host factors that modulate this response to infection is of great interest for designing prophylactic or therapeutic HIV interventions. Therefore, in this research we will investigate why some cats develop either no or only mild immunodeficiency from infection with FIV. First, we will determine differences in the make-up of viruses that cause disease and those that don't cause disease by molecular examination of the viral proteins and their modifications. Next, we will examine how these different viruses alter the function of dendritic cells (DC), which are the ""master"" regulators of the immune response. Finally, we will investigate how the immune system, and specifically how helper and cytotoxic lymphocytes, respond to the different viruses. These studies will give us insight into whether trying to manipulate the early phase of immunodeficiency virus infection through increasing DC function, or reducing immune activation, may improve the outcome of infection. Further, these studies will clarify whether the nature and degree of the host immune response determines the onset of immunodeficiency, and how important the composition of the particular virus is.
Program
Discovery Grants Program - Individual
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
217493-2009
Name nom
Bienzle, Dorothee
Department département
Pathobiology
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2009
Award amount
50000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1011
Committee name en
Integrative Animal Biology
Committee name fr
Biologie Animale Intégrative
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
5512
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Veterinary sciences
Research subject fr
Médecine vétérinaire
Partie
4
Nb partie
5
Application title
Host response to lentiviral infection
Keyword
NSERC
Application summary
Among lentiviruses, only the human immunodeficiency virus (HIV) and the feline immunodeficiency virus (FIV) utilize a combination of ubiquitous chemokine and specific T-cell receptors for viral entry, and cause immunodeficiency in their natural hosts. FIV has co-evolved with domestic and wild cats for a longer time than HIV has with humans, and disease associated with FIV infection develops more gradually in cats than immunodeficiency in HIV-infected people. Further, some cats infected with FIV do not get ill at all, while most others eventually succumb to the disease. Identifying feline host factors that modulate this response to infection is of great interest for designing prophylactic or therapeutic HIV interventions. Therefore, in this research we will investigate why some cats develop either no or only mild immunodeficiency from infection with FIV. First, we will determine differences in the make-up of viruses that cause disease and those that don't cause disease by molecular examination of the viral proteins and their modifications. Next, we will examine how these different viruses alter the function of dendritic cells (DC), which are the ""master"" regulators of the immune response. Finally, we will investigate how the immune system, and specifically how helper and cytotoxic lymphocytes, respond to the different viruses. These studies will give us insight into whether trying to manipulate the early phase of immunodeficiency virus infection through increasing DC function, or reducing immune activation, may improve the outcome of infection. Further, these studies will clarify whether the nature and degree of the host immune response determines the onset of immunodeficiency, and how important the composition of the particular virus is.